Abbott's Volt™ Pulsed Field Ablation System is the next generation of cardiac ablation technology built on a distinctive balloon-in-basket design to treat people with heart rhythm disorders such as ...
VANCOUVER, British Columbia, October 01, 2025--(BUSINESS WIRE)--Kardium, a private medical device company that's advancing the way the world treats atrial fibrillation (AF), today announced the ...
The financing aims to bolster CardiaCare’s clinical programme for AFib indications.
U.S. healthcare group Abbott Laboratories ( ABT ), announced on Tuesday that its Volt pulsed field ablation system was used for the first time in Canada at Montreal's McGill University Health Centre ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
MISSISSAUGA, ON, Sept. 15, 2026 /CNW/ -- Abbott (NYSE: ABT) today announced that its Volt™ Pulsed Field Ablation System, designed to deliver more precise, targeted energy with fewer catheter exchanges ...
First Canadian commercial use of Abbott’s Volt Pulsed Field Ablation System advances minimally invasive atrial fibrillation care: Mississauga, Ontario Thursday, September 17, 20 ...